PSAMP
CERE

P. Schoenfeld Asset Management (PSAM)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-796,440
Closed -$32.6M – 52
2024
Q2 		$32.6M Buy
796,440
+50,000
+7% +$2.08M 7.87% 2
2024
Q1 		$31.6M Buy
+746,440
New +$31.4M 9.01% 2

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s CERE Position: Q3 2024 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 796,440 shares — an estimated $32.6M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $32.6M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 796,440 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $32.6M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $32.6M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q3 2024, filed 14 Nov 2024.